Rigel Pharmaceuticals Inc
NASDAQ: RIGL · HEALTHCARE · BIOTECHNOLOGY
Updated 2026-04-29
Rigel Pharmaceuticals Inc (RIGL) Stock Valuation Analysis
Fair value estimate, historical valuation range, and quality signals for RIGL.
Valued
Fundamentals support the current valuation. Strong combination of growth, quality, and price.
RIGL historical valuation range
Where current P/E sits in RIGL's own 5Y range.
RIGL intrinsic value (DCF)
DCF-based fair value estimate vs current market price.
Intrinsic value calculated using discounted cash flow (DCF) model based on projected free cash flows, discount rate, and terminal growth assumptions. A positive margin of safety indicates the current price is below estimated fair value, providing a cushion against estimation error.
RIGL valuation signals
Quick-read green flags, caution flags, and risks based on current metrics.
P/E Ratio — History
Current: 1.57x
P/S Ratio — History
Current: 1.92x
Is RIGL overvalued in 2026?
Rigel Pharmaceuticals Inc (RIGL) currently trades at $29.22 per share with a market capitalization of $564,749,000.00. Based on our multi-factor framework, the stock looks attractively valued with a Smart Value Score of 79/100. This score blends growth quality, financial health, and price attractiveness into a single institutional-grade read.
The stock trades at a P/E ratio of 1.6x, below its 5-year median of 2.0x.
Looking at its own history, RIGL is currently trading cheaper than 67% of the last 5Y on P/E. This places it in the 33th percentile of its historical range, a reasonable but unremarkable position.
Our discounted cash flow model estimates RIGL's intrinsic value at $294.92 per share, against the current market price of $29.22. This implies a margin of safety of +88.15%. A meaningful cushion exists against model error, making this a reasonable risk-adjusted entry.
Financial quality is a concern. The Piotroski F-Score of 0/9 flags weakening fundamentals that deserve closer scrutiny before the valuation case can be fully trusted.
Bottom line: RIGL looks attractively valued on our framework, with a Smart Value Score of 79/100. The combination of reasonable price, healthy growth, and quality fundamentals makes it worth serious consideration.
Frequently asked questions
Is RIGL overvalued in 2026?
Based on a Smart Value Score of 79/100, RIGL is not overvalued. Fundamentals support the current price and offer reasonable margin of safety.
What is RIGL's fair value?
Our DCF model estimates RIGL's intrinsic value at $294.92 per share, versus the current price of $29.22. This produces a margin of safety of +88.15%.
What P/E ratio does RIGL trade at?
RIGL trades at a P/E of 1.6x on trailing twelve-month earnings, compared to its 5-year median of 2.0x.
Is RIGL a buy based on valuation?
WallStSmart does not issue buy or sell recommendations. Our Smart Value Score of 79/100 reflects the combined read on growth, quality, and price. The profile skews favorable for long-term accumulation.
How does RIGL's valuation compare to its history?
On P/E, RIGL currently sits in the 33th percentile of its own 5Y range. That is below its long-run median relative to where it has traded over the period.
What is RIGL's Smart Value Score?
RIGL's Smart Value Score is 79/100. The Smart Value Score is a proprietary WallStSmart metric blending growth quality, financial health, and valuation attractiveness into a single 0-100 read. Scores above 75 are rare and indicate strong multi-factor alignment.